1. Home
  2. DCTH vs VBNK Comparison

DCTH vs VBNK Comparison

Compare DCTH & VBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • VBNK
  • Stock Information
  • Founded
  • DCTH 1988
  • VBNK 1980
  • Country
  • DCTH United States
  • VBNK Canada
  • Employees
  • DCTH 76
  • VBNK N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • VBNK Commercial Banks
  • Sector
  • DCTH Health Care
  • VBNK Finance
  • Exchange
  • DCTH Nasdaq
  • VBNK Nasdaq
  • Market Cap
  • DCTH 426.3M
  • VBNK 373.6M
  • IPO Year
  • DCTH N/A
  • VBNK 2021
  • Fundamental
  • Price
  • DCTH $11.52
  • VBNK $11.67
  • Analyst Decision
  • DCTH Strong Buy
  • VBNK Strong Buy
  • Analyst Count
  • DCTH 4
  • VBNK 4
  • Target Price
  • DCTH $24.00
  • VBNK $17.50
  • AVG Volume (30 Days)
  • DCTH 850.4K
  • VBNK 48.2K
  • Earning Date
  • DCTH 08-04-2025
  • VBNK 09-04-2025
  • Dividend Yield
  • DCTH N/A
  • VBNK 0.61%
  • EPS Growth
  • DCTH N/A
  • VBNK N/A
  • EPS
  • DCTH N/A
  • VBNK 0.79
  • Revenue
  • DCTH $53,850,000.00
  • VBNK $79,960,487.00
  • Revenue This Year
  • DCTH $155.42
  • VBNK $12.97
  • Revenue Next Year
  • DCTH $37.93
  • VBNK $43.72
  • P/E Ratio
  • DCTH N/A
  • VBNK $14.70
  • Revenue Growth
  • DCTH 1068.87
  • VBNK N/A
  • 52 Week Low
  • DCTH $7.17
  • VBNK $8.51
  • 52 Week High
  • DCTH $18.23
  • VBNK $18.38
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 32.83
  • VBNK 59.18
  • Support Level
  • DCTH $12.11
  • VBNK $11.53
  • Resistance Level
  • DCTH $14.15
  • VBNK $11.75
  • Average True Range (ATR)
  • DCTH 0.57
  • VBNK 0.20
  • MACD
  • DCTH -0.16
  • VBNK 0.03
  • Stochastic Oscillator
  • DCTH 9.67
  • VBNK 90.77

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About VBNK VersaBank

VersaBank is a Canadian Schedule I chartered bank with a difference. It has 3 operating segments: Digital Banking Canada, Digital Banking USA and DRTC. It's, cloud-based, business-to-business deposit and lending model provides valued-added solutions to Canadian financial intermediary partners, enabling them to focus on growing their own businesses faster and more profitably. It obtains all of its deposits and provides the majority of its loans and leases electronically, with deposit and lending solutions for financial intermediaries that allow them to excel in their core businesses. In addition, leveraging its internally developed IT security software and capabilities, Company established a wholly owned, subsidiary. Geographically located in Canada and USA.

Share on Social Networks: